Please browse here to find research papers published by our clients utilising Ozgene mice.


1. Human growth hormone presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejection. (Not categorised)
De, Kluyver R; Fernando, GJ; Frazer, IH.; Leggatt, GR; Matsumoto, K; Zhong, J
Immunol Cell Biol, 2004 Dec;82(6):577
Centre for Immunology and Cancer Research, University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
2. Genetically tagging endothelial cells in vivo: bone marrow derived cells do not contribute toal Growth and Development. (Tg pronuclear injection)
Begley, CG.; Gothert, JR; Gottgens, B; Gustin, SE; Hall, MA; Izon, DJ; Jane, SM; Schmidt, U
Blood, 2004 Sep 15;104(6):1769-77. Epub 2004 Ju
Division of Cancer Biology, Telethon Institute for Child Health Research, Centre for Child Health Research and Western Australian Institute for Medical Research, University of Western Australia, West Perth, Australia.
3. The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal (KO non-conditional)
Beales, M; Böse, J; Gruber, AD; Hafner, M; Helming, L; Koentgen, F; Lengeling, A.; Schiebe, S; Wegener, I
J Biol, 2004;3(4):15. Epub 2004 Aug
German Research Center for Biotechnology (GBF), 38124 Braunschweig, Germany.
4. Edd, the murine hyperplastic disc gene, is essential for yolk sac vascularization and chorioallantoic fusion. (KO non-conditional)
Biben, C; Dunwoodie, SL; Henderson, MJ; Hird, SL; Ormandy, CJ; Saunders, DN; Sutherland, RL; Watts, CK.; Withington, SL
Mol Cell Biol, 2004 Aug;24(16):7225
Cancer Research Program, Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, 2010 NSW, Australia.
5. Novel approaches to models of Alzheimer's disease pathology for drug screening and development. (Tg lentiviral)
Chamblin, B; Koentgen, F; McMahon, L; Nair, A; Ramabhadran, R.; Shaughnessy, L; Thomas, MB; Wakefield, J
J Mol Neurosci, 2004;24(1):23
Tranzyme, Inc., Research Triangle Park, NC 27709, USA.
6. The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1. (Bruce4 ES cells)
Barton, LM; Begley, CG.; Broccardo, C; Delaney, L; Deveaux, S; Erber, WN; Frampton, J; Gothert, JR; Gottgens, B; Green, AR.; Kinston, S; Knezevic, K; Kotsopoulou, E; Murphy, G; Piltz, S; Sanchez, MJ
Mol Cell Biol, 2004 Mar;24(5):1870
Department of Hematology, Cambridge Institute for Medical Research, University of Cambridge, United Kingdom.
7. All known in vivo functions of the Oct-2 transcription factor require the C-terminal protein domain. (KO non-conditional)
Corcoran, LM; Dietrich, W; Humbert, PO.; Koentgen, F; Veale, M
J Immunol, 2004 Mar 1;172(5):296
The Walter and Eliza Hall Institute, Parkville, Victoria, Australia.

7 Publication(s)